@article{5382773a5ae34afe9e1c1e2f2dcab62a,
title = "Split dosing of coronavirus disease 2019 vaccines provides noninferior antibody responsiveness to conventional vaccine dosing",
keywords = "SARS-CoV-2, adverse vaccine reaction, antibody responsiveness, covid-19, graded immunization, split dosing, vaccine allergy, vaccines",
author = "Amal Musa and Macy Wood and Andrew Rorie and May, {Sara M.} and Graaff, {Joel Van De} and Poole, {Jill A.}",
note = "Funding Information: The authors thank Rhonda Walenz, BS, and Amy Nelson, BS, MT (ASP), for assistance with clinical study administration and coordination, Paul D. Fey, PhD, and Rick Starlin, MD, for study design assistance, and Lisa Chudomelka, MA, for assistance with manuscript submission. The authors also thank the subjects for participation in this study. Disclosures: Dr Poole has received funding from AstraZeneca and is a site investigator for human clinical research studies from GlaxoSmithKline, Takeda, and AstraZeneca, all unrelated to this project. The authors have no other conflicts of interest to report. Funding: The authors report intramural research funding within the Division of Allergy and Immunology and Department of Pathology and Microbiology.",
year = "2022",
month = dec,
doi = "10.1016/j.anai.2022.08.995",
language = "English (US)",
volume = "129",
pages = "794--796",
journal = "Annals of Allergy, Asthma and Immunology",
issn = "1081-1206",
publisher = "American College of Allergy, Asthma and Immunology",
number = "6",
}